In conclusion, our study provides evidence that implicates ferroptosis in the progression of NASH and highlights the hepatoprotective effects of icariin by inhibiting ferroptosis, particularly through the activation of Nrf2 and its downstream genes, xCT and GPX4. This evidence concerns the gene GPX4 and metabolic dysfunction-associated steatohepatitis.